Janet Novotny

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Janet Novotny sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed upper quartile by trial count

Janet Novotny: 3 sponsored US clinical trials, none currently recruiting.

Janet Novotny sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Healthy, with 1 trials.

Upper-quartile sponsor footprint

Janet Novotny sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

COMPLETED NA

Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria

NCT01944579
COMPLETED NA

The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction

NCT01748617
COMPLETED NA

Grape Polyphenol Kinetics in Humans

NCT01751750

Therapeutic Areas

Healthy 1

How the Janet Novotny archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Healthy (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Janet Novotny: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Janet Novotny sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Janet Novotny10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
Janet Novotny sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Janet Novotny sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Janet Novotny page

3 registered trials is a research-attention snapshot, not an endorsement of Janet Novotny or any single study.

  • None of Janet Novotny's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Healthy is the condition Janet Novotny studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Janet Novotny pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.